Dehydration-Induced Acute Kidney Injury

Introduction to Dehydration-Induced AKI

Dehydration is a well-established cause of acute kidney injury (AKI) and represents one of the most common and preventable mechanisms of kidney damage in clinical practice, as stated by the British Medical Journal and Kidney International 1, 2

Volume depletion (hypovolaemia) reduces renal perfusion pressure, directly impairing glomerular filtration and leading to acute tubular injury, according to the British Medical Journal 1

Patients taking RAAS inhibitors (ACE inhibitors, ARBs), diuretics, NSAIDs, or SGLT2 inhibitors have blocked compensatory mechanisms that normally protect kidney perfusion during hypovolemia, as reported by The Lancet Diabetes and Endocrinology 4, 5
COVID-19 patients commonly present with dehydration on admission and experience increased insensible fluid losses from fever and tachypnea, as noted by the British Medical Journal 1
Patients with diabetes taking metformin or SGLT2 inhibitors should stop these medications during dehydration to prevent lactic acidosis and AKI, as recommended by The Lancet Diabetes and Endocrinology 4, 5

Ensuring adequate hydration is essential in preventing and treating AKI, but fluid administration must be guided by hemodynamic assessment, according to Kidney International 2, 6
For patients without shock, confusion, or swallowing difficulty, oral rehydration with any available rehydration drink or potable water should be initiated immediately, as suggested by Circulation 7
4% to 9% carbohydrate-electrolyte drinks are preferred over plain water for exertional dehydration, as recommended by Circulation 7
Intravenous fluid administration should be based on repeated assessment of fluid status and dynamic tests of fluid responsiveness, not empiric boluses, as stated by Kidney International 2
Avoid indiscriminate fluid administration in patients with established AKI, as inappropriate attempts to "reverse" AKI can lead to fluid overload and worsen kidney function, according to Kidney International 2, 6

Stop metformin due to risk of lactic acidosis and monitor renal function carefully, as recommended by The Lancet Diabetes and Endocrinology 4, 5
Stop SGLT2 inhibitors (canagliflozin, dapagliflozin, empagliflozin) due to risk of dehydration, diabetic ketoacidosis, and AKI, as suggested by The Lancet Diabetes and Endocrinology 4, 5
Monitor GLP-1 receptor agonists closely as dehydration can lead to serious illness; encourage adequate fluid intake, as recommended by The Lancet Diabetes and Endocrinology 4, 5

Measure serum urea, creatinine, and electrolytes at least every 48 hours or more frequently if clinically indicated, as suggested by the British Medical Journal 1
Assess fluid status by clinical examination (peripheral perfusion, capillary refill, pulse rate, blood pressure, postural hypotension) and fluid balance daily, according to the British Medical Journal 1
Monitor urine output, with oliguria representing a warning sign but having multiple etiologies beyond hypovolemia, as noted by Kidney International 2, 6
Use early warning scores (NEWS2) for patients with deteriorating clinical condition, as recommended by the British Medical Journal 1

Do not assume oliguria always indicates hypovolemia requiring fluid boluses – oliguria has multiple etiologies and inappropriate fluid administration can create a vicious cycle of fluid overload worsening kidney function, as stated by Kidney International 2, 6
Do not use the outdated term "pre-renal AKI" as it is often misinterpreted as "hypovolemic" and encourages indiscriminate fluid administration, according to Kidney International 2
Do not continue nephrotoxic medications during dehydration without careful risk-benefit assessment and monitoring, as recommended by Kidney International 6, 8